Earnings FeedTerminal

⌘K

Home/Insiders/Eramian Daniel G

ED

SEC Insider//CIK 0001355850

Eramian Daniel G

CIK 00013558501 companySEATTLE, WA

Transactions

14

Companies

1

Filings

3

CIK

0001355850

Recent Transactions

14 trades

Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-28$0.57/sh−6,800→ 1,981,761 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-28$0.57/sh−9,731→ 1,972,030 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-28$0.57/sh−3,000→ 1,988,761 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-28$0.58/sh−10,000→ 1,961,761 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-28$0.57/sh−269→ 1,971,761 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-28$0.57/sh−200→ 1,988,561 total
Sale
CTI BIOPHARMA CORP
Common Stock
2012-06-28$0.58/sh−20,000→ 1,941,761 total
Award
CTI BIOPHARMA CORP
Common Stock
2012-06-27+27,415→ 1,991,761 total
Award
CTI BIOPHARMA CORP
Common Stock
2012-01-03+1,211,953→ 1,971,939 total
Award
CTI BIOPHARMA CORP
Common Stock
2012-01-03+1,211,953→ 1,971,939 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2011-12-31−498,329→ 759,986 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2011-12-31−498,329→ 759,986 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2009-12-31−5,040→ 1,790,495 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2009-12-31−5,040→ 1,790,495 total

Companies

1

CTI BIOPHARMA CORP
EVP, Corporate Communications

Recent Filings

3

Address

501 ELLIOTT AVE. W. SUITE #400

SEATTLE, WA, 98119

View on SEC.gov